Post

Misleading claims by Popp et al. in BMJ Journal

Rapid Response to Editor of BMJ Evidence Based Medicine

Re: Popp M, Kranke P, Meybohm P, et al. Evidence on the efficacy of ivermectin for COVID-

19: another story of apples and oranges. BMJ Evidence-Based Medicine Published Online

First: 20 August 2021. doi: 10.1136/bmjebm-2021-111791

Andrew Bryant MSc

Population Health Sciences Institute, Newcastle University

Theresa A Lawrie MBBCh PhD 

Edmund J Fordham PhDFInstP

EbMCsquared CIC

To the Editor

The integrity of our meta-analyses of trial data on Ivermectin for prevention and treatment of Covid-19 is questioned by authors of a recent Cochrane review. We agree that misleading information on Covid-19 treatment abounds in social and mainstream media as well as in journal opinion pieces. However, Bryant et al is a non-commissioned research paper that strictly followed PRISMA systematic review guidelines.

Download pdf

Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.

Please Contribute

Let's Get Ivermectin Approved

Safe, cheap, beats Covid

Please support our campaign with a monthly or a single amount to help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.

Bird Group/EBMC Squared is a not-for-profit Community Interest Company (CIC).

All funds received will be invested in our activities to promote public health and wellbeing.

Please contribute

Your monthly or single contribution will help us keep pressure on authorities to approve the safe drug ivermectin that will help beat covid-19 and save lives around the world.